The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials
Abstract
Purpose: Older patients are significantly underrepresented in cancer clinical trials. A literature review was undertaken to identify the barriers that impede the accrual of this vulnerable population onto clinical trials and to determine what specific strategies are needed to improve the representation of older patients in research studies. Methods: A systematic literature search was undertaken using several different strategies to identify relevant articles. Results: Nine of 31 relevant papers from 159 citations were included. Age is a significant barrier to recruitment; only a quarter to one third of potentially eligible older patients are enrolled onto trials. Physicians' perceptions, protocol eligibility criteria with restrictions on comorbid conditions, and functional status to optimize treatment tolerability are the most important reasons resulting in the exclusion of older patients. Other barriers include the lack of social support and the need for extra time and resources to enroll these patients. Conversely, older patients do not view their age as an important reason for refusing trials. Conclusion: Specific clinical trials confined to older patients should be conducted to evaluate tumor biology, treatment tolerability, and the effect of comorbid conditions. Protocol designs need to stratify for age and be less restrictive with respect to exclusions on functional status, comorbidity, and previous cancers, such that results are generalizable to older patients. Physician education to dispel unfounded perceptions, improved access to available clinical trials, and provision of personnel and resources to accommodate the unique requirements of an older population are possible solutions to remove the barriers of ageism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004) · JAMA · doi:10.1001/jama.291.22.2720 · Cited by 2,078
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Lewis, J. H., Kilgore, M. L., Goldman, D. P., Trimble, E. L., Kaplan, R., Montello, M. J., Housman, M. G., & Escarce, J. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.010 · Cited by 1,031
Kriegsman, D. M. W., Penninx, B. W. J. H., Van Eijk, J. T. M., Boeke, A. J. P., & Deeg, D. J. H. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00274-0 · Cited by 939
Talarico, L., Chen, G., & Pazdur, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.175 · Cited by 727
Lara, P. N., Higdon, R., Lim, N., Kwan, K., Tanaka, M., Lau, D. H. M., Wun, T., Welborn, J., Meyers, F. J., Christensen, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1728 · Cited by 588
Sateren, W. B., Trimble, E. L., Abrams, J., Brawley, O., Breen, N., Ford, L., McCabe, M., Kaplan, R., Smith, M., Ungerleider, R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.056 · Cited by 535
Barriers to Clinical Trial Participation by Older Women With Breast Cancer
Kemeny, M. M., Peterson, B. L., Kornblith, A. B., Muss, H. B., Wheeler, J., Levine, E., Bartlett, N., Fleming, G., & Cohen, H. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.124 · Cited by 465
Weick, J., Kopecky, K., Appelbaum, F., Head, D., Kingsbury, L., Balcerzak, S., Bickers, J., Hynes, H., Welborn, J., Simon, Sr., et al. (1996) · Blood · doi:10.1182/blood.v88.8.2841.bloodjournal8882841 · Cited by 411
Public Attitudes Toward Participation in Cancer Clinical Trials
Comis, R. L., Miller, J. D., Aldigé, C. R., Krebs, L., & Stoval, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.105 · Cited by 393
Cancer in the elderly: why so badly treated?
Fentiman, I. S., Tirelli, U., Monfardini, S., Schneider, M., Festen, J., Cognetti, F., & Aapro, M. S. (1990) · The Lancet · doi:10.1016/0140-6736(90)91075-l · Cited by 345
Representation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy
Jenkins, V, & Fallowfield, L. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1142 · Cited by 316
Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?
Yee, K. W. L., Pater, J. L., Pho, L., Zee, B., & Siu, L. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.044 · Cited by 304
Self-citationTejeda, H. A., Green, S. B., Trimble, E. L., Ford, L., High, J. L., Ungerleider, R. S., Friedman, M. A., & Brawley, O. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.12.812 · Cited by 269
Social and Economic Factors in the Choice of Lung Cancer Treatment
Greenberg, E. R., Chute, C. G., Stukel, T., Baron, J. A., Freeman, D. H., Yates, J., & Korson, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803103181006 · Cited by 264
Ellis, P. M. (2000) · Annals of Oncology · doi:10.1023/a:1008342222205 · Cited by 260
Ellis, P. M., Butow, P. N., Tattersall, M. H. N., Dunn, S. M., & Houssami, N. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3554 · Cited by 244
Advani, A. S., Atkeson, B., Brown, C. L., Peterson, B. L., Fish, L., Johnson, J. L., Gockerman, J. P., & Gautier, M. (2003) · Cancer · doi:10.1002/cncr.11213 · Cited by 204
Christman, K. (1992) · JAMA · doi:10.1001/jama.1992.03490010059030 · Cited by 196
Silliman, R. A., Guadagnoli, E., Weitberg, A. B., & Mor, V. (1989) · Journal of Gerontology · doi:10.1093/geronj/44.2.m46 · Cited by 191
Kornblith, A. B., Kemeny, M., Peterson, B. L., Wheeler, J., Crawford, J., Bartlett, N., Fleming, G., Graziano, S., Muss, H., Cohen, H. J., et al. (2002) · Cancer · doi:10.1002/cncr.10792 · Cited by 180
Impact of Referral Patterns on the Use of Chemotherapy for Lung Cancer
Earle, C. C., Neumann, P. J., Gelber, R. D., Weinstein, M. C., & Weeks, J. C. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.142 · Cited by 176
Relationship Between Age at Diagnosis and Treatments: Received by Cancer Patients
Mor, V., Masterson‐Allen, S., Goldberg, R. J., Cummings, F. J., Glicksman, A. S., & Fretwell, M. D. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb06313.x · Cited by 172
Giovanazzi-Bannon, S., Rademaker, A., Lai, G., & Benson, A. B. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2447 · Cited by 172
Willingness to Participate in Clinical Treatment Research Among Older African Americans and Whites
Brown, D. R., & Topcu, M. (2003) · The Gerontologist · doi:10.1093/geront/43.1.62 · Cited by 161
Siminoff, L. A., Zhang, A., Colabianchi, N., Sturm, C. M. S., & Shen, Q. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1203 · Cited by 149
Lima, C. M. S. R., Herndon, J. E., Kosty, M. P., Clamon, G. H., & Green, M. R. (2001) · Cancer · doi:10.1002/cncr.10174 · Cited by 143
Mills, N., Donovan, J. L., Smith, M., Jacoby, A., Neal, D. E., & Hamdy, F. C. (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00020-5 · Cited by 142
Wright, J. R., Whelan, T. J., Schiff, S., Dubois, S. J., Crooks, D. L., Haines, P. T., DeRosa, D., Roberts, R. S., Gafni, A., Pritchard, K. I., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.187 · Cited by 140
Rose, J. H., O’Toole, E. E., Dawson, N. V., Lawrence, R. H., GURLEY, D. N., Thomas, C. L., Hamel, M. B., & Cohen, H. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.050 · Cited by 138
Why patients don’t take part in cancer clinical trials: an overview of the literature
Cox, K., & McGarry, J. (2003) · European Journal of Cancer Care · doi:10.1046/j.1365-2354.2003.00396.x · Cited by 135
Christman, K. (1992) · JAMA · doi:10.1001/jama.268.1.57 · Cited by 130
What influences participation in clinical trials in palliative care in a cancer centre?
Ling, J., Rees, E., & Hardy, J. R. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00330-5 · Cited by 125
Factors Affecting the Use of Palliative Radiotherapy in Ontario
Huang, J., Zhou, S., Groome, P. A., Tyldesley, S. K., Zhang-Solomans, J., & Mackillop, W. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.137 · Cited by 124
Cb, B., Jl, C., & Ellerton, J. A. (1980) · PubMed · Cited by 110
Factors that influence the recruitment of patients to Phase III studies in oncology
Wright, J. R., Crooks, D. L., Ellis, P. M., Mings, D., & Whelan, T. J. (2002) · Cancer · doi:10.1002/cncr.10864 · Cited by 76
ACUTE MYELOID LEUKAEMIA IN THE ELDERLY: BIOLOGY AND TREATMENT
Johnson, P. R. E., & Yin, J. A. L. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb04622.x · Cited by 57
Clinical trial participation among patients enrolled in the Glioma Outcomes Project
Chang, S. M., Barker, F. G., Schmidt, M. H., Sloan, A. E., Kasper, R. S., Phillips, L. E., Shih, K. M., Hariharan, S., Berger, M. S., & The Glioma Outcomes Investigators (2002) · Cancer · doi:10.1002/cncr.10536 · Cited by 54
Callahan, E. H., Thomas, D. C., Goldhirsch, S. L., & Leipzig, R. M. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00014-7 · Cited by 50
Segelov, E., Tattersall, M. H. N., & Coates, A. (1992) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058119 · Cited by 45
Recruiting Older African American Men to a Cancer Screening Trial (The AAMEN Project)
Ford, M. E., Havstad, S. L., & Tilley, B. C. (2003) · The Gerontologist · doi:10.1093/geront/43.1.27 · Cited by 39
Representation of Asian Americans in Clinical Cancer Trials
Alexander, G. A., Chu, K. C., & Ho, R. C. S. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00198-8 · Cited by 36
Entry into clinical trials in breast cancer: the importance of specialist teams
Twelves, C. J., Thomson, C. S., Young, J. M., & Gould, A. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10126-5 · Cited by 32
Sociodemographic and Clinical Predictors of Participation in Two Randomized Trials
The Collaborative Ocular Melanoma Study Group (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00157-x · Cited by 20
Postoperative radiation therapy for adult soft tissue sarcomas: A retrospective study
Antognoni, P., Cerizza, L., Vavassori, V., Molteni, M., Garavello, M., Salvadore, M., Cerati, M., & Tordiglione, M. (1992) · Annals of Oncology · doi:10.1093/annonc/3.suppl_2.s103 · Cited by 19
Cited by
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
Bluethmann, S. M., Mariotto, A. B., & Rowland, J. H. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0133 · Cited by 1,146
“Cancer patients older than age 65 have been largely excluded from clinical trials (30), precluding opportunities to develop greater insight about the unique needs of older as well as long-term survivors.”
BackgroundFogel, D. B. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.08.001 · Cited by 1,035
Global cancer incidence in older adults, 2012 and 2035: A population‐based study
Pilleron, S., Sarfati, D., Janssen‐Heijnen, M., Vignat, J., Ferlay, J., Bray, F., & Soerjomataram, I. (2019) · International Journal of Cancer · doi:10.1002/ijc.31664 · Cited by 670
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies
Unger, J. M., Cook, E., Tai, E., & Bleyer, A. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156686 · Cited by 665
Metadata
- Authors
- Townsley, C. A., Selby, R., & Siu, L. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-05-01
- Volume
- 23
- Issue
- 13
- Pages
- 3112-3124
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2168272173
- Cited by
- 583
- References
- 48
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.